Published in Epidemiol Infect on August 01, 1993
Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays. Virology (2014) 0.78
Mallard or chicken? Comparing the isolation of avian influenza A viruses in embryonated Mallard and chicken eggs. Infect Ecol Epidemiol (2015) 0.75
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Host cell-mediated variation in H3N2 influenza viruses. Virology (1987) 2.57
Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol (1990) 2.45
Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. Virology (1988) 1.54
Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus. J Virol (1991) 1.32
Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology (1989) 1.21
Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). Bull World Health Organ (1987) 1.13
Naturally occurring temperature-sensitive influenza A viruses of the H1N1 and H3N2 subtypes. J Gen Virol (1980) 1.06
Sequence of an influenza virus hemagglutinin determined directly from a clinical sample. Proc Natl Acad Sci U S A (1990) 0.96
A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch Virol (1990) 0.95
Amino acid substitution at position 226 of the hemagglutinin molecule of influenza (H1N1) virus affects receptor binding activity but not fusion activity. Virology (1988) 0.84
The antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells. J Gen Virol (1990) 0.79
E-MSD: the European Bioinformatics Institute Macromolecular Structure Database. Nucleic Acids Res (2003) 7.79
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology (1997) 4.96
5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus. Nucleic Acids Res (1979) 4.90
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res (2002) 4.85
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.50
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
p47 is a cofactor for p97-mediated membrane fusion. Nature (1997) 4.02
Conformational analysis of nucleic acids revisited: Curves+. Nucleic Acids Res (2009) 3.76
PDBe: Protein Data Bank in Europe. Nucleic Acids Res (2009) 3.48
E-MSD: an integrated data resource for bioinformatics. Nucleic Acids Res (2004) 3.43
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol (1972) 2.78
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell (1998) 2.54
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell (1983) 2.42
E-MSD: improving data deposition and structure quality. Nucleic Acids Res (2006) 2.41
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med (1999) 2.41
Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36
Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med (2001) 2.34
Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology (1999) 2.31
Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23
Physical and genetic analysis of cosmids from the vicinity of the cystic fibrosis locus. Nucleic Acids Res (1987) 2.16
Structure of the host-derived sequences present at the 5' ends of influenza virus mRNA. Nucleic Acids Res (1980) 2.14
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine (1994) 2.09
Intra- and interrater variation in the evaluation of videofluorographic swallowing studies. Dysphagia (1998) 2.07
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
The properties of three baculoviruses from closely related hosts. Virology (1977) 1.93
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG (2000) 1.88
Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial. Am Rev Respir Dis (1971) 1.85
Duration of survival in traffic accident fatalities. Med J Aust (1968) 1.85
Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J Biol Chem (1982) 1.84
P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med (1981) 1.79
An NSF function distinct from ATPase-dependent SNARE disassembly is essential for Golgi membrane fusion. Nat Cell Biol (1999) 1.76
Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials. Am Rev Respir Dis (1973) 1.76
Simian virus 40-induced T and tumor antigens. J Virol (1969) 1.76
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Theoretical studies of the selective binding to DNA of two non-intercalating ligands: netropsin and SN 18071. Nucleic Acids Res (1983) 1.73
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Glucose and insulin responses to barley products: influence of food structure and amylose-amylopectin ratio. Am J Clin Nutr (1994) 1.63
Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res Hum Retroviruses (1992) 1.60
Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists. Mol Cell Biol (1985) 1.57
Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J Gen Virol (1975) 1.51
The flexibility of the nucleic acids: (II). The calculation of internal energy and applications to mononucleotide repeat DNA. J Biomol Struct Dyn (1986) 1.50
Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50
Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet (1971) 1.49
Quality assurance methods and phantoms for magnetic resonance imaging: report of AAPM nuclear magnetic resonance Task Group No. 1. Med Phys (1990) 1.48
Studies on the mechanism of influenza virus entry into cells. J Gen Virol (1979) 1.46
Human MHC class II molecules as differentiation markers. Immunogenetics (1982) 1.45
Child and adolescent mental health service use. HoNOSCA as an outcome measure. Br J Psychiatry (2000) 1.45
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
Evidence for antigenic variation in influenza A nucleoprotein. Virology (1979) 1.43
Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol (2000) 1.42
Evidence for Chlamydia pneumoniae of non-human origin. J Gen Microbiol (1993) 1.40
Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology (1993) 1.39
Facial reanimation after acoustic neuroma excision: the patient's perspective. Laryngoscope (1991) 1.39
Intestinal transit of solid and liquid components of a meal in health. Gastroenterology (1984) 1.39
TT virus contaminates first-generation recombinant factor VIII concentrates. Blood (2001) 1.39
Control of falciparum malaria. Public Health (1992) 1.39
Mitral valve disease associated with use of anorexigenic medications. Ann Thorac Surg (1997) 1.39
Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS (1991) 1.39
Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. Bull World Health Organ (1969) 1.38
Screening for toxoplasmosis. Public Health (1990) 1.38
Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68. J Hyg (Lond) (1970) 1.37
Receptor for transferrin may be a "target" structure for natural killer cells. Proc Natl Acad Sci U S A (1983) 1.37
Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci (2001) 1.37
Immunofluorescent studies on the inhibition of influenza A and B viruses in mammalian cell cultures by amines and ammonium compounds. J Gen Virol (1968) 1.37
The intracellular distribution of influenza virus matrix protein and nucleoprotein in infected cells and their relationship to haemagglutinin in the plasma membrane. J Gen Virol (1988) 1.35
Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.34
Sequence analysis of the haemagglutinin of A/Taiwan/1/86, a new variant of human influenza A(H1N1) virus. J Gen Virol (1987) 1.34
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis (1978) 1.33
Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol (2000) 1.33
Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care (Engl) (2005) 1.30
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature (1977) 1.30
The effect of surgical approach on blood flow to the femoral head during resurfacing. J Bone Joint Surg Br (2007) 1.28
EMDep: a web-based system for the deposition and validation of high-resolution electron microscopy macromolecular structural information. J Struct Biol (2003) 1.28
Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology (1994) 1.28
Demonstration of the "5-8 S" ribosomal sequence in HeLa cell ribosomal precursor RNA. J Mol Biol (1974) 1.27
The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res (1998) 1.26
The metabolism of the isomeric decalones. Biochem J (1966) 1.26
Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis. J Hyg (Lond) (1982) 1.25
In vivo selection of an influenza A2 strain resistant to amantadine. Nature (1970) 1.24
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry (2005) 1.22
A comprehensive classification of nucleic acid structural families based on strand direction and base pairing. Nucleic Acids Res (1992) 1.22
Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmacol Ther (1980) 1.21
Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology (1989) 1.20
Nomenclature for tracer kinetics. Int J Appl Radiat Isot (1968) 1.20